Jyrki Mattila Insider Trading $BSTCE BIOSPECIFICS TECHNOLOGIES CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jyrki Mattila.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jyrki Mattila. Jyrki Mattila is Director in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Executive Vice President in AUXILIUM PHARMACEUTICALS INC ($AUXL) and Chief Business Officer in Lipocine Inc. ($LPCN) and Executive VP, Business Dev. in Recro Pharma, Inc. ($REPH).
Jyrki Mattila in BIOSPECIFICS TECHNOLOGIES CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jyrki Mattila: Director
Holdings: 15,376 shares
Latest Transaction: May 24 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jyrki Mattila in BIOSPECIFICS TECHNOLOGIES CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AUXL, BSTCE, LPCN, REPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | M | 41.82 | 3,750 | 156,825 | 11,250 | |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | M | 37.64 | 15,000 | 564,600 | 0 | |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Sell | S | 62.06 | 18,750 | 1,163,625 | 376 | 19.1 K to 376 (-98.03 %) |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Buy | M | 41.82 | 3,750 | 156,825 | 19,126 | 15.4 K to 19.1 K (+24.39 %) |
| May 24 2019 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Buy | M | 37.64 | 15,000 | 564,600 | 15,376 | 376 to 15.4 K (+3,989.36 %) |
| Mar 19 2018 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | A | 41.82 | 15,000 | 627,300 | 15,000 | |
| Apr 23 2015 | BSTCE | BIOSPECIFICS TECHN ... | Mattila Jyrki | Director | Option Exercise | A | 37.93 | 15,000 | 568,950 | 15,000 |
Page: 1